Shopify Inc. (SHOP) reported solid Q4 2024 earnings, with earnings per share (EPS) of $0.44, slightly beating expectations of $0.43, and revenue reaching $2.81 billion, exceeding the forecasted $2.73 billion. The company's market capitalization stood at $160.03 billion. Shopify's strong performance reflects continued growth in e-commerce demand and effective platform enhancements, reinforcing its position as a leading provider of online retail solutions.
S&P Global (SPGI) reported strong Q4 2024 earnings, with earnings per share (EPS) of $3.77, surpassing expectations of $3.36, and revenue reaching $3.59 billion, exceeding the forecasted $3.43 billion. The company's market capitalization stood at $166.37 billion. The better-than-expected performance reflects strong demand for financial data, analytics, and credit ratings, reinforcing S&P Global's position as a key player in the financial services industry.
Coca-Cola (KO) reported strong Q4 2024 earnings, with earnings per share (EPS) at $0.55, beating expectations of $0.52, and revenue reaching $11.5 billion, surpassing the forecasted $10.7 billion. The company's market capitalization stood at $290.82 billion. Solid consumer demand and effective cost management contributed to the better-than-expected results, highlighting Coca-Cola's resilience despite economic uncertainties.
The NFIB Small Business Optimism Index for January 2025 came in at 102.8, falling short of the expected 104.6 and declining from 105.1 in the previous month. This drop suggests that small business confidence weakened, possibly due to concerns over economic conditions, inflation, or policy uncertainty.
Meanwhile, the Redbook Index, which tracks U.S. retail sales, showed a 5.3% year-over-year increase, down from the previous 5.7%. The slowdown indicates a moderation in consumer spending, which could reflect shifting consumer behavior or tighter financial conditions.
The February 2025 University of Michigan survey showed rising inflation expectations and weakening consumer confidence. 1-year inflation expectations surged to 4.3% (from 3.3%), while 5-year expectations edged up to 3.3% (from 3.2%), reflecting growing concerns about persistent price pressures. Meanwhile, consumer sentiment dropped to 67.8, missing the 71.9 forecast and declining from 71.1 in January, while consumer expectations fell to 67.3 (from 69.3). The data suggests that inflation worries are mounting, and confidence in the economy is deteriorating, which could impact consumer spending and influence the Federal Reserve’s policy stance.
The January 2025 U.S. Nonfarm Payrolls (NFP) report showed weaker-than-expected job growth, with 143K new jobs added, missing the 169K forecast and significantly lower than 307K in December. However, the unemployment rate fell to 4.0%, and wages saw a 0.5% monthly increase.
Overall, the report suggests a cooling labor market with resilient wage growth, which could factor into the Federal Reserve’s monetary policy outlook, while the drop in unemployment provides some positive momentum.
Amazon's Q4 2024 earnings exceeded expectations. The company reported an EPS of $1.86, beating the forecasted $1.47. Revenue came in at $187.8 billion, slightly above the expected $187.33 billion. With a market capitalization of $2.51 trillion, Amazon continues to demonstrate strong financial performance, driven by robust e-commerce and cloud computing growth.
Philip Morris (PM) reported Q4 2024 earnings with an EPS of $1.49, slightly below the expected $1.50. However, revenue exceeded forecasts at $9.71 billion versus the expected $9.5 billion. The company's market capitalization stands at $203.65 billion.
AstraZeneca (AZN) delivered a strong Q4 2024 earnings report, with earnings per share (EPS) of $2.09, nearly doubling the expected $1.06. Revenue came in at $14.89 billion, surpassing the forecasted $14.15 billion. The company's market capitalization stands at $223.71 billion.
Eli Lilly (LLY) reported strong results for Q4 2024, with earnings per share (EPS) of $5.32, slightly above the expected $5.30. The company generated revenue of $13.53 billion, just below the anticipated $13.78 billion. Eli Lilly's market capitalization stands at $758.33 billion.
The U.S. labor market displayed mixed signals in the fifth week of 2025. Challenger Job Cuts rose to 49.795K in January, up from 38.792K in December, though job cuts decreased by 39.5% year-over-year, contrasting with the 11.4% increase in the previous year. Initial Jobless Claims increased to 219K, above the forecast of 214K and the prior 208K, while Continuing Jobless Claims rose to 1.886 million, slightly exceeding the expected 1.870 million and the previous 1.850 million. The 4-week moving average of jobless claims climbed to 216.75K, reflecting a gradual rise in unemployment claims.
Nonfarm Productivity for Q4 2024 grew by 1.2%, falling short of the expected 1.5% and the prior 2.3%, indicating a slowdown in workforce efficiency. Meanwhile, Unit Labor Costs increased by 3.0%, below the anticipated 3.4% but well above the previous 0.5%, pointing to rising labor expenses. The data suggests a tightening labor market with growing cost pressures as businesses navigate the evolving economic landscape.
MicroStrategy (MSTR) reported a larger-than-expected loss in Q4 2024, with earnings per share (EPS) at -$3.20, missing the expected -$0.12. Revenue came in at $120.7 million, slightly below the forecast of $123 million. Despite the earnings miss, the company maintains a market capitalization of $84.89 billion, largely influenced by its Bitcoin holdings and strategic focus on digital assets.